Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 ,inter alia, to consider and approve 1. Consider and approve ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Fredun Pharmaceuticals Ltd has informed BSE that a Board meeting is scheduled for 25th May, 2026 to consider and approve three key matters: (1) Audited Financial Results for Q4 and FY ended 31st March, 2026 (standalone and consolidated), (2) Recommendation of final dividend for FY 2025-26, and (3) Recommendation of bonus equity shares subject to shareholder approval. The company has also announced closure of the trading window under SEBI insider trading regulations until 48 hours after the financial results are declared. This is a standard prior intimation filing as required under SEBI LODR regulations.
The meeting notice is routine, but the potential bonus share issuance and dividend recommendation are positive signals for shareholders. The actual impact on the stock price will depend on the approved figures when results are declared.